HAM
Hillcrest Asset Management’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $8M | Sell |
184,010
-26,370
| -13% | -$1.15M | 1.22% | 52 |
|
|
2021
Q3 | $10.5M | Buy |
210,380
+74,972
| +55% | +$3.75M | 1.51% | 39 |
|
|
2021
Q2 | $8.53M | Sell |
135,408
-25,330
| -16% | -$1.6M | 1.15% | 54 |
|
|
2021
Q1 | $14.9M | Sell |
160,738
-690
| -0.4% | -$64.1K | 1.74% | 27 |
|
|
2020
Q4 | $14.5M | Sell |
161,428
-398
| -0.2% | -$35.7K | 1.97% | 15 |
|
|
2020
Q3 | $16.7M | Sell |
161,826
-4,367
| -3% | -$451K | 2.96% | 3 |
|
|
2020
Q2 | $13.1M | Sell |
166,193
-54,467
| -25% | -$4.31M | 2.4% | 8 |
|
|
2020
Q1 | $12.8M | Buy |
220,660
+1,450
| +0.7% | +$83.9K | 3.07% | 6 |
|
|
2019
Q4 | $11.8M | Buy |
219,210
+38,562
| +21% | +$2.08M | 1.8% | 29 |
|
|
2019
Q3 | $9.44M | Sell |
180,648
-5,440
| -3% | -$284K | 1.51% | 40 |
|
|
2019
Q2 | $8.99M | Buy |
186,088
+1,130
| +0.6% | +$54.6K | 1.4% | 45 |
|
|
2019
Q1 | $9.34M | Buy |
184,958
+49,322
| +36% | +$2.49M | 1.5% | 42 |
|
|
2018
Q4 | $8.04M | Buy |
135,636
+30
| +0% | +$1.78K | 1.93% | 21 |
|
|
2018
Q3 | $8.93M | Buy |
135,606
+20,204
| +18% | +$1.33M | 1.7% | 34 |
|
|
2018
Q2 | $5.83M | Sell |
115,402
-1,096
| -0.9% | -$55.3K | 1.09% | 54 |
|
|
2018
Q1 | $6.13M | Buy |
+116,498
| New | +$6.13M | 1.23% | 51 |
|